Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Eisai, Tonic and the Cancer Drugs Fund - A bold and brave media relations campaign

by Reynolds-MacKenzie for Lundbeck/Accretio. ... Driet: The Drinking Diet - by Reynolds-MacKenzie for Lundbeck/Accretio.

Finalists revealed for Communiqué Awards 2016

Finalists revealed for Communiqué Awards 2016 for Otsuka Lundbeck. Turning concepts into reality: AbbVie's sustainable healthcare initiative. ... for Lundbeck/Accretio. GeneratioNext School Science Event. by Roche Products Ltd. Pedalling Sepsis up the public health agenda.

FDA turns down Teva's Huntington's disease drug

FDA turns down Teva's Huntington's disease drug Teva's drug is a 'deuterated' form of VMAT-2 inhibitor tetrabenazine - the active ingredient in Lundbeck's already-approved Xenazine product - with a modified structure that seeks to improve the ... The product brought in around $330m in sales for

Pharma's reputation rises, but pricing still a sore point

Pharma's reputation rises, but pricing still a sore point AbbVie came in second, followed by Lundbeck with Janssen climbing four places to take the number four slot ahead of Novo Nordisk.

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’ Rexulti. depression/schizophrenia. serotonin 5-HT1a / dopamine D2 partial agonist. Otsuka/Lundbeck. USA.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics